Healthcare and Life Science
Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development
Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into new markets such as cell ...
Challenges and advances in asthma treatment
An In-depth Conversation with Dr. Andrew Potter of Whaddon Medical Centre Asthma remains a persistent challenge in healthcare, affecting both adults and children alike. In a recent podcast, Dr. Andrew Potter, GP lead at Wadden Medical Center in Milton Keynes, shared his valuable insigh...
Know your customer: strategic considerations for AI-powered provider segmentation
Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered pr...
Owlstone Medical partners with the FDA to advance the identification of volatile organic compounds in breath and expand its Breath Biopsy VOC Atlas.
Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and techniques to enhance its work in the field of breath-based biomarkers of disease Project will also help extend ...
Introducing Gluetacs Therapeutics to the UK market
Gluetacs Therapeutics (www.gluetacs.com), a pioneering biotech company located in the innovative Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, is making significant strides in the field of targeted protein degradation, both in molecular glue (GLUE) and bifunctional de...
FUJIFILM Irvine Scientific Adds Key Products To Its Life Sciences Portfolio From FUJIFILM Wako Chemicals U.S.A.
Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe Sales agreement aligns business and commercial operations to maximize customer benefit SANTA ANA, Calif: FUJIFILM...
impulse’s next-gen female entrepreneurs eye up $1trillion FemTech sector
With the FemTech market set to be worth $1trillion by 2027 (McKinsey & Company), impulse, the University of Cambridge’s unique entrepreneurship programme, has seen a sharp rise in the number of participants contributing novel innovations to this exciting sector. ...
Transforming healthcare: the power of purpose-led partnerships
In this episode, Dr Bipin Patel sits down with Samuel Hollis, Country President and Managing Director at Novartis to explore the key elements of forming impactful healthcare partnerships. ...
Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001
ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025 Brighton, UK: Enterprise Therapeu...
Hospital prosthetics service moves to high-tech new home
An Addenbrooke’s service that offers vital support for amputees and others officially opened on the 23rd Sept at a high-tech new home after nearly quarter of a century at the hospital. ...